The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).
Related Resources
Webcast
AHRMM presents a four-part series on successful collaboration with suppliers.
Book
This book was written to enhance the strategic contributions of the healthcare supply chain in a way that is most meaningful to hospitals’ an
White Papers
AHRMM19 CQO Summit White Paper entitled CQO: The Power of Clinical Integration.
On-Demand Educational Webinars
A panel of health care industry leaders shares their insights and experiences in creating a best-practice supply chain that supports the intersection…
Podcasts
AHRMM Podcast on how supply chain should be interdepartmentally conversing to determine the handling of human-origin medical products and their UDIs.
Webcast
In this three-part series, Lisa Tonkinson and Chris Wiekert discuss how the Revenue Cycle can impact your supply chain when embarking on a new soft